Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU ‘Newmood’ research investigating genetic links to treat depression with new drugs

29.06.2004


120 million people worldwide suffer from depression. An EU-funded research project launched recently will help to uncover the genetic factors linked to depression to develop new drug treatments. The Integrated Project, named NEWMOOD, has received €7.2 million in funding from the EU’s Sixth Research Framework Programme (FP6) and aims to identify genes involved in triggering depression. This will help researchers to develop new drugs over the next five years to treat it and improve understanding of its causes. The drugs are set to revolutionise antidepressant drugs, which have not changed much over the past 30 years. The project, co-ordinated by the University of Manchester (United Kingdom) involves partners from 13 laboratories in 10 European countries including Estonia, France, Germany, Hungary, Italy, the Netherlands, Poland, Slovenia and Spain.

“Depression is a widespread issue and represents a serious health problem in Europe. Everybody can feel sad. But depression is a severe and long-term problem where people feel hopeless and their professional and private life is hampered,” says European Research Commissioner Philippe Busquin. “Traditional drugs mainly target brain chemicals, and are only partially effective. By looking into the genetics of depression EU researchers can go to the very roots of the illness, and help prevent and cure it in innovative ways. European scientists working together can make a difference and achieve a quantum leap in the fight against depression”.

Feeling blue



Depression, which is marked by symptoms of reduced interest and pleasure, weight and appetite changes, agitation and fatigue, is believed to be caused by genetic and environmental factors. Chronic stress, such as long term illness or bereavement, can trigger depression in those genetically predisposed to the condition. Counselling is often used alongside drug treatment, but the NEWMOOD research hopes to find more effective drug treatments by identifying genes affecting depression in mice and rats, and later in humans.

New drugs to take effect sooner

Currently, most antidepressants work by boosting levels of serotonin in the brain, a chemical that allows nerve cells in the brain to communicate with one another. However, such treatments can take weeks to have an effect and only work in around 50% of patients. It is hoped the new drugs will be more effective and quicker to take effect.

Targeting and understanding depression

This gene research will help to provide new targets for the drugs and improve understanding of the key causes of depression. Researchers will develop a microchip carrying 800 genes to test which ones are active in healthy and depressed animals and humans. They will test the effects of these depression-related genes by altering their activity in genetically modified mice. Animal depression can be observed in mice by lower than usual interest in sweetened water and a tendency not to struggle as much when suspended from their tails.

Fabio Fabbi | EU Commission
Further information:
http://europa.eu.int

More articles from Health and Medicine:

nachricht Study shows novel protein plays role in bacterial vaginosis
13.12.2019 | University of Arizona Health Sciences

nachricht Illinois team develops first of a kind in-vitro 3D neural tissue model
12.12.2019 | University of Illinois College of Engineering

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Virus multiplication in 3D

Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies. Two studies now provide fascinating insights into their unusual propagation strategy at the atomic level.

For viruses to multiply, they usually need the support of the cells they infect. In many cases, only in their host’s nucleus can they find the machines,...

Im Focus: Cheers! Maxwell's electromagnetism extended to smaller scales

More than one hundred and fifty years have passed since the publication of James Clerk Maxwell's "A Dynamical Theory of the Electromagnetic Field" (1865). What would our lives be without this publication?

It is difficult to imagine, as this treatise revolutionized our fundamental understanding of electric fields, magnetic fields, and light. The twenty original...

Im Focus: Highly charged ion paves the way towards new physics

In a joint experimental and theoretical work performed at the Heidelberg Max Planck Institute for Nuclear Physics, an international team of physicists detected for the first time an orbital crossing in the highly charged ion Pr⁹⁺. Optical spectra were recorded employing an electron beam ion trap and analysed with the aid of atomic structure calculations. A proposed nHz-wide transition has been identified and its energy was determined with high precision. Theory predicts a very high sensitivity to new physics and extremely low susceptibility to external perturbations for this “clock line” making it a unique candidate for proposed precision studies.

Laser spectroscopy of neutral atoms and singly charged ions has reached astonishing precision by merit of a chain of technological advances during the past...

Im Focus: Ultrafast stimulated emission microscopy of single nanocrystals in Science

The ability to investigate the dynamics of single particle at the nano-scale and femtosecond level remained an unfathomed dream for years. It was not until the dawn of the 21st century that nanotechnology and femtoscience gradually merged together and the first ultrafast microscopy of individual quantum dots (QDs) and molecules was accomplished.

Ultrafast microscopy studies entirely rely on detecting nanoparticles or single molecules with luminescence techniques, which require efficient emitters to...

Im Focus: How to induce magnetism in graphene

Graphene, a two-dimensional structure made of carbon, is a material with excellent mechanical, electronic and optical properties. However, it did not seem suitable for magnetic applications. Together with international partners, Empa researchers have now succeeded in synthesizing a unique nanographene predicted in the 1970s, which conclusively demonstrates that carbon in very specific forms has magnetic properties that could permit future spintronic applications. The results have just been published in the renowned journal Nature Nanotechnology.

Depending on the shape and orientation of their edges, graphene nanostructures (also known as nanographenes) can have very different properties – for example,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

The Future of Work

03.12.2019 | Event News

First International Conference on Agrophotovoltaics in August 2020

15.11.2019 | Event News

Laser Symposium on Electromobility in Aachen: trends for the mobility revolution

15.11.2019 | Event News

 
Latest News

Supporting structures of wind turbines contribute to wind farm blockage effect

13.12.2019 | Physics and Astronomy

Chinese team makes nanoscopy breakthrough

13.12.2019 | Physics and Astronomy

Tiny quantum sensors watch materials transform under pressure

13.12.2019 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>